Interventional Cardiology

Patients under 65 years undergoing TAVR exhibit a higher comorbidity burden and greater all-cause mortality

Early transcatheter aortic-valve replacement is more effective than clinical surveillance in reducing adverse outcomes in patients with asymptomatic severe aortic stenosis.

The SCAI has presented detailed guidance to help interventional cardiologists optimise primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction.

A new study has found that new-onset left bundle-branch block after surgical aortic valve replacement is linked to increased long-term mortality…

Researchers have found a modest increase in risk-adjusted 30-day mortality rates following transcatheter aortic valve replacement (TAVR) between 2019 and 2022.

The CALIPSO trial has unveiled evidence supporting the use of optical coherence tomography in guiding percutaneous coronary intervention for moderate to severe calcified lesions.

A recent randomised open-label trial reveals important findings on the efficacy of optical coherence tomography in guiding angioplasty for left main coronary artery lesions.

The NOTION-2 trial is a pivotal study that focused on low surgical risk patients aged 75 years or younger, including both tricuspid and bicuspid aortic stenosis (AS) cases…